Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of [99mTc]Tc-tilmanocept with [99mTc]Tc-sulphur colloids and [99mTc]Tc-albumin colloids for sentinel lymph node detection in patients with cutaneous malignancies of the head.
Ooms M, von Mallek D, Kaiser HJ, Hölzle F, Mottaghy FM, Modabber A. Ooms M, et al. Among authors: von mallek d. Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):870-880. doi: 10.1007/s00259-022-06017-y. Epub 2022 Oct 28. Eur J Nucl Med Mol Imaging. 2023. PMID: 36305908 Free PMC article.
Multicentric 68Ga-PSMA PET radiomics for treatment response assessment of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer.
Gutsche R, Gülmüs G, Mottaghy FM, Gärtner F, Essler M, von Mallek D, Ahmadzadehfar H, Lohmann P, Heinzel A. Gutsche R, et al. Among authors: von mallek d. Front Nucl Med. 2023 Sep 14;3:1234853. doi: 10.3389/fnume.2023.1234853. eCollection 2023. Front Nucl Med. 2023. PMID: 39355016 Free PMC article.
Prostate-specific membrane antigen radioligand therapy of prostate cancer.
Beheshti M, Heinzel A, von Mallek D, Filss C, Mottaghy FM. Beheshti M, et al. Among authors: von mallek d. Q J Nucl Med Mol Imaging. 2019 Mar;63(1):29-36. doi: 10.23736/S1824-4785.19.03155-8. Epub 2019 Jan 15. Q J Nucl Med Mol Imaging. 2019. PMID: 30644306 Review.
Dosing to rash?--The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rash.
Steffens M, Paul T, Hichert V, Scholl C, von Mallek D, Stelzer C, Sörgel F, Reiser B, Schumann C, Rüdiger S, Boeck S, Heinemann V, Kächele V, Seufferlein T, Stingl J. Steffens M, et al. Among authors: von mallek d. Eur J Cancer. 2016 Mar;55:131-9. doi: 10.1016/j.ejca.2015.11.022. Epub 2016 Jan 25. Eur J Cancer. 2016. PMID: 26820683
[SPECT/CT: Benefit and indications of hybrid imaging].
Ahmadzadehfar H, Muckle M, Essler M, Biersack HJ, von Mallek D. Ahmadzadehfar H, et al. Among authors: von mallek d. Dtsch Med Wochenschr. 2015 Mar;140(6):434-8. doi: 10.1055/s-0041-101022. Epub 2015 Mar 16. Dtsch Med Wochenschr. 2015. PMID: 25774736 Review. German. No abstract available.
[Clinical medical technology--a physician's task].
von Mallek D. von Mallek D. Dtsch Med Wochenschr. 2013 Aug;138(33):1664. doi: 10.1055/s-0033-1349465. Epub 2013 Aug 2. Dtsch Med Wochenschr. 2013. PMID: 23913353 German. No abstract available.
42 results